Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03756168
Other study ID # CS0518
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 14, 2018
Est. completion date July 2, 2019

Study information

Verified date January 2024
Source Venus Concept
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this clinical study is to assess the safety and efficacy of using a 1060 nm diode laser for non-invasive fat reduction of the flanks.


Description:

Open-label, baseline-controlled, evaluator-blind, multi-center study evaluating a 1060 nm diode laser for non-invasive fat reduction of the flanks. The study will enroll up to 50 subjects requesting non-invasive lipolysis of the flanks. Each subject will receive a single study treatment. Subjects will be followed at six weeks and twelve weeks post-treatment. Twelve week outcome will be compared to baseline.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 2, 2019
Est. primary completion date July 2, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - able to read, understand and voluntarily provide written informed consent - healthy male or female > 18 years of age seeking treatment for unwanted fat in the abdomen - BMI score is less then 30 - agree to not making any major changes in their diet or lifestyle during the course of the study - able and willing to comply with the treatment / follow up schedule and requirements - women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrolment and for the duration of the study, have a negative urine pregnancy test baseline Exclusion Criteria: - pregnant in the last 3 months intending to become pregnant, postpartum or nursing in the last 6 months - any previous liposuction / lipo-sculpture or any type of surgical procedure in the treatment area in the past 12 months - history of immunosuppression / immune deficiency disorders including AIDS and HIV infection, or use of immunosuppressive medications, 6 month prior to and during the course of the study - History of hyperlipidemia, diabetes, hepatitis, blood coagulopathy or excessive bleeding - Use of antiplatelet medications (81 mg of acetylsalicylic acid daily is permitted), anticoagulants, thrombocytes or any-inflammatory medications within 2 weeks of treatment - Having a history of skin cancer or any other cancer in the area to be treated, including presence of malignant or pre-malignant pigmented lesions - Having a permanent implant in the treatment area such as a metal plate or injected chemical substance such as silicone pr parenteral gold therapy (gold sodium thiomalate) - Use of medications, herbs or food supplements and vitamins known to induce photosensitivity to light exposure at the wavelength used history of photosensitivity disorder - Suffering from significant skin conditions in the treatment area or inflammatory skin conditions including but not limited to open lacerations, abrasions, herpes sores, cold sores, active infections - Tattoos in the treatment area - Poor quality skin (laxity) - Abdominal wall, muscular abnormality or hernia on physical examination - Unstable weight within the last 6 months (+ or - 3% weight change in the prior six months) - Participation in another clinical study involving the same anatomical areas within the last 6 months - History of keloid and hypertrophic scar formation or poor wound healing in the treatment area - As per the investigators discretion any physician or mental condition which may make it unsafe for the subject to participate

Study Design


Related Conditions & MeSH terms


Intervention

Device:
1060nm Diode laser
All subjects received a single treatment with Venus Bliss' 1064 nm laser administered to the flanks Venus Bliss is a non-invasive medical aesthetic device designed for body contouring. The device contains four 1060 nm diode laser applicators which are 60x60 mm in size. It has a separate RF/PEMF applicator, but this was not used in this study. There is a belt included with the system to allow for the secure attachment of the applicators to the treatment area.

Locations

Country Name City State
United States UT Southwestern Medical Centre Dallas Texas
United States Laser and Skin Surgery Center of Northern California Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
Venus Concept

Country where clinical trial is conducted

United States, 

References & Publications (1)

Kang A, Kislevitz M, Wamsley C, Barillas J, Hoopman J, Kenkel J, Kilmer S. Clinical evaluation of the safety and efficacy of a 1060 nm diode laser for non-invasive fat reduction of the flanks. J Cosmet Dermatol. 2023 Nov;22(11):3017-3025. doi: 10.1111/joc — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the Percentage of Fat Thickness From Baseline to 12-weeks Post-treatment Change in the percentage of fat thickness of the adipose layer as measured by ultrasound at 12 weeks post-treatment as compared to baseline. Week 12
Secondary Change in Abdominal Circumference From Baseline to 12 Weeks Post-treatment Change in the abdominal circumference at 12 weeks post-treatment as compared to baseline Week 12
Secondary Subject Satisfaction Subject satisfaction with treatment at 12 weeks was assessed using the 5-point Likert subject satisfaction scale. 5 is very satisfied, while 1 is very unsatisfied Week 12
Secondary Treatment Pain Treatment pain assessed immediately post-treatment as measured using the Wong-Baker Faces Scale. Pain was measured on a scale from 0-10 (10 worst pain ever, to 0 no pain at all) Day 1
See also
  Status Clinical Trial Phase
Completed NCT03756350 - Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen) N/A
Not yet recruiting NCT05318716 - The Fat Analysis Trial (FAT) - Assessing the Impact of Lipo-aspirate Processing N/A